Preclinical CRO Market Global Scenario, Market Size, Outlook, Trend, and Forecast, 2019 – 2028

Overview

The global preclinical CRO market size was valued at US$ 4.53 billion in 2020 and is expected to grow at a CAGR of 8.2% from 2021 to 2028; and is expected to reach US$ 8.52 billion by 2028. Preclinical contract research organization (CRO) offers the R&D development which gives the experience, learning and aptitude which is required for a pharmaceutical or medical equipment from the designing phase to distribution. CRO involves researchers, restorative workforce, legislative and industry contacts and specialists. Before trying on people in clinical preliminaries it must be tried to ensure it is protected and prospering. This requires testing on the animals under supervision.

Market Dynamics

R&D budget for the development of drug has increased the demand of global preclinical contract organization (CRO). According to Servier Research Institute, 50% of failure during the preclinical phase is basically due to toxicology which is predicted to push the demand of preclinical CRO services in the upcoming years. The readily available skilled human resources, low cost of devices, and the increasing prevalence of chronic diseases, are anticipated to fuel the growth of the market. Increasing competition between top players leads to the growth of preclinical CRO market. Companies are also trying to introduce new and advanced products. Additionally, clinical trial is an important phase before introducing any product and to get better results, companies depend on contract research organizations. In addition, with increase in new and complex microorganism which causes different diseases, complex drugs are entering clinical trials and increasing R&D expenses are the responsible factors for global preclinical Contract Research Organization (CRO) growth. Therefore, increase in technology and advancements in healthcare infrastructure are expected to foster the preclinical CRO market growth.

The Preclinical research organisation (CRO) market is segmented on the basis of service, by end-user and by region. By service, it is categorized into Bioanalysis and Drug Metabolism Pharmacokinetics (DMPK) Studies, Toxicology Testing and others. Based on end user, it is categorized into Biopharmaceutical Companies, Government and Academic Institutes and Medical Device. By region it is categorised as North America (US, Canada), Asia Pacific (China, Japan, India, South Korea, Australia, Rest of Asia Pacific), Europe (Germany, France, UK, Italy, Russia, Spain), Rest of World (Latina America, Middle East & Africa).

The key players involved in the preclinical research organisation (CRO) include Envigo Corporation, MPI Research, Eurofins Scientific, IQVIA, PAREXEL International Corporation, Charles River, ICON PLC, PRA Health Sciences, Medpace, Laboratory Corporation of America Holdings, Pharmaceutical Product Development, LLC, WuXi AppTec, and MD Biosciences among others.

Global Preclinical Research Organisation (CRO) Market Segmentation

Global Preclinical Contract Research Organisation (CRO) market is segmented on the basis of service, end-user and region as follows:

  • By Service
    • Bioanalysis and Drug Metabolism Pharmacokinetics (DMPK) Studies
    • Toxicology Testing
    • Others
    • By End-user
      • Biopharmaceutical Companies
      • Government and Academic Institutes
      • Medical Device
      • By Region
        • North America
          • US
          • Canada
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest of Asia Pacific
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
    • Spain
  • Rest of World
    • Latina America
    • Middle East & Africa

The key players involved in the Global Preclinical Contract Research Organisation (CRO) market among others include

  • Envigo Corporation
  • MPI Research
  • Eurofins Scientific
  • IQVIA
  • PAREXEL International Corporation
  • Charles River
  • ICON PLC
  • PRA Health Sciences
  • Medpace Inc
  • Laboratory Corporation of America Inc.
  • Pharmaceutical Product Development
  • LLC
  • WuXi AppTec
  • MD Biosciences
Back to top

Payment Options

Single User : $5,295
Five User: $6,195
Enterprise : $8,199
Datapack : $2,199
Short Report : $3,099